Jörg Freudenberger

Jörg Freudenberger, Intertek - Qepler Summits And Conferences

Jörg Freudenberger

Manager Strategy & Global Business Development, Chemicals & Pharma
Intertek
Switzerland
Intertek (Schweiz) AG

Related Sessions:

Qepler - 2nd Genotoxic Impurities in Pharmaceuticals Virtual Summit thumbnail Details

2nd Annual Genotoxic Impurities in
Pharmaceuticals Summit 2021

Genotoxic Impurities in Pharmaceuticals strategies & new methodologies: analysis, in silico & regulations.
  • 15 Jul 2021
  • Virtual,
  • Pharma
Day 2: Friday, 16 July 2021
CASE STUDY: A Journey for Risk Mitigation of Genotoxic Impurities in Pharmaceutical Products.
  • Risk Assessment of Raw Materials, Intermediates, Process Contact Materials and Container Closure Systems.
  • Analytical Screening for Nitrosamines and other Genotoxic Impurities.
  • Monitoring of critical Targets in Pharmaceuticals over their Shelf Life.
View Details
This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Cookies Policy.